FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes

As of February 22, 2024, the FDA was continuing to embrace the idea that there is a “continuum of risk” with combusted tobacco as the riskiest and e-cigarettes being substantially less risky. As a result, FDA promotes e-cigarettes as a way for smokers to reduce risk. This view is based on the fact that e-cigarettesContinue reading “FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes”

Cannabis use linked to increase in heart attack and stroke risk

Many people think cannabis is “medicine” and so ignore its heath effects. Abra Jeffers, Amy Byers, Salome Keyhani and I just published Association of cannabis use with cardiovascular outcomes among US adults in the Journal of the American Heart Association that found that cannabis use is associated with adverse cardiovascular events with heavier use (moreContinue reading “Cannabis use linked to increase in heart attack and stroke risk”

E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone

It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”

Banning menthol leads a quarter of menthol smokers to quit

The two justifications for the FDA’s proposed product standard prohibiting menthol cigarettes and cigars are (1) it will reduce youth initiation, and (2) it will help menthol smokers to quit. Now Sarah Mills and colleagues have published a review and meta-analysis of the effects of menthol bans around the world, The Impact of Menthol CigaretteContinue reading “Banning menthol leads a quarter of menthol smokers to quit”

Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame

Yogi Hendlin, Eileen Han and Pam Ling’s new paper Pharmaceuticalisation as the tobacco industry’s endgame provides a detailed analysis of how the multinational tobacco companies have developed and used the companies efforts to reposition themselves a source for “clean” nicotine while simultaneously maintaining and expanding their sales of cigarettes and other “traditional” tobacco products whereContinue reading “Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame”

Replacing 50% of cigs with ecigs or HTP had no lung benefit

E-cigarette advocates and tobacco harm reduction advocates, as well as the FDA, have long promoted a 50% reduction in cigarette smoking as a positive outcome when assessing the value of e-cigarettes (recent example). The FDA’s use of this benchmark is particularly surprising because in 2021 FDA scientists published a meta-analysis of the effects of smokers reducingContinue reading “Replacing 50% of cigs with ecigs or HTP had no lung benefit”

Cochrane Collaborative concludes that e-cigs as medicines help a few people shop smoking (again); still ignoring differences between medicines and consumer products as well as dual use

On January 8, 2024, the Cochrane Collaborative published yet another meta-analysis of randomized controlled trials concluding that e-cigarettes help a few people stop smoking. While industry and other pro-e-cigarette interests will make a big deal of this, the fact is that there is nothing new here. Here is their primary conclusion: There is high certaintyContinue reading “Cochrane Collaborative concludes that e-cigs as medicines help a few people shop smoking (again); still ignoring differences between medicines and consumer products as well as dual use”

Youth living in vapefree homes much less likely to use e-cigs

While the reason for enacting smokefree laws and implementing voluntary smokefree policies has been to protect people from secondhand smoke, a well-established side effect is that they help adult smokers quit and help prevent youth smoking (laws, home policies). Now Jeremy Staff and his colleagues have shown that kids living in vapefree households are muchContinue reading “Youth living in vapefree homes much less likely to use e-cigs”

Biden follows Obama and Trump by caving to industry pressure to delay menthol ban

Last week the Biden White House announced it was delaying a decision on the FDA’s well-reasoned product standards that would end the use of menthol in cigarettes and cigars, sparking outrage from leaders in the African American community: The White House is ignoring the real human cost of delay. Based on the Biden FDA’s analysis, everyContinue reading “Biden follows Obama and Trump by caving to industry pressure to delay menthol ban”

Drop in smoking not correlated with increased youth vaping

E-cigarette advocates have often argued that the increase in youth e-cigarette use is not a problem because it represents youth shifting from cigarettes. Earlier work based on analysis of trends and risk profiles in youth participating in the National Youth Tobacco Survey has contradicted this assertion, showing that e-cigarettes were attracting youth at low riskContinue reading “Drop in smoking not correlated with increased youth vaping”